|
|
List of sponsors 
If you are interested in sponsorship opportunities at this event then please contact:
Edward Low, Project Manager
Email: edward.low@terrapinn.com
Tel: 0207 827 5994
Fax: 0207 242 1508
|
Gold sponsors
|
Pall Corporation is the global leader in the rapidly growing field of filtration, separations and purification, especially in the biopharmaceutical industry for the production of biotech and biopharmaceutical products.
Pall's Life Sciences Group is fully integrated to offer product lines that start in the laboratory with drug discovery, gene manipulation and proteomics applications, and extend into drug development, process scale up, through to full drug manufacturing production and patient delivery. Pall's extensive expertise helps its customers throughout the drug approval regulatory process, and its filtration systems and validation services offer drug manufacturers the quickest and surest path through the regulatory process and onto the market. As Mr Jerold M. Martin, Senior Vice President and Global Technical Director for Pall Life Sciences' BioPharmaceuticals division said, "Pall Corporation is committed to developing the most advanced, cost-effective virus filtration products that maximize customers' opportunity for success."
|
Cobra Biomanufacturing is a company focused on providing innovative manufacturing solutions for the production of biopharmaceutical products and gene medicines. We provide world-class GMP contract manufacturing solutions for the development of biopharmaceutical products from discovery through clinical trial manufacture. At Cobra we offer our customers the innovative production technologies, expert manufacturing skills and the high level of analytical capabilities they demand.
|
Cardinal Health is a full-service contract manufacturer of biotech and sterile pharmaceutical products. Our multiple manufacturing facilities, combined with our experience with all types of sterile products, provide flexible capacity and efficiencies. From clinical quantities to full-scale production, we can develop and manufacture virtually any sterile product, including:
· Lyophilization
· Prefilled syringes
· Blow/Fill/Seal
· Vials
Tel (toll-free): 1-866-720-3148
Email: bsls.sales@cardinal.com
www.cardinal.com/pts
|
Silver sponsor
|
Arent Fox is a recognised leader in many areas, including life sciences, real estate, and intellectual property. With offices in Washington, DC and New York, the Firm has a wide range of expertise in litigation, corporate securities and transactions, financial restructuring and bankruptcy, government relations and regulation, labor and employment law, finance, tax, corporate compliance, and the global business market.
Arent Fox counsels companies navigating the complex legal path from financing to research and development to regulatory approval to global distribution. Our team focuses on advising clients on how to manage all aspects of the legal issues raised by biologic products. Arent Fox is especially well poised to help clients anticipate the shifts in the federal government's policies and procurement programs as well as the evolving regulations with respect to "follow-on" biologics. Our attorneys craft regulatory, business and IP solutions for manufacturers of biological products regulated by the FDA's Center for Biologics Evaluation and Research. The firm counsels clients through product development - from clinical trials to manufacturing, licensing, approvals and patent protection.
|
AVANT Immunotherapeutics, Inc. is engaged in the discovery, development and commercialization of products that harness the human immune system to prevent and treat disease. We are developing a broad portfolio of vaccines and immunotherapeutics addressing a wide range of applications including bacterial and viral diseases, cardiovascular diseases, biodefense and food safety. These include single dose, oral vaccines that protect against important disease causing agents, a novel, proprietary vaccine candidate for cholesterol management, and an immunotherapeutic to improve patient outcomes after cardiac surgery. Our strategy is to demonstrate proof of concept for our products before leveraging their value through partnerships. Our current collaborations encompass the development of an oral human rotavirus vaccine, vaccines to combat threats of biological warfare, and vaccines addressed to human food safety and animal health. Our products address large market opportunities for which current therapies are inadequate or nonexistent.
AVANT is a biopharmaceutical company that uses novel applications of immunology to prevent and treat diseases. We have assembled a broad portfolio of technologies and intellectual property that give us a strong competitive position in the vaccines arena, and six of our products are in clinical development. Our goal is to become a leading developer of innovative vaccines that address health care needs on a global basis.
|
As the worldwide leader in clinical research, Quintiles has in-depth expertise in vaccines and an exceptional track record: since 2000, we have conducted 70 vaccine studies involving more than 144,000 patients in 56 countries. Our experience spans Phases I-IV studies in the prevention of influenza, HIV, hepatitis, pneumococcal, pertussis, RSV, anthrax, plague, smallpox, melanoma, and many other vaccine areas. Worldwide, you can count on Quintiles to deliver the results you need. Visit us at www.quintiles.com.
|
Biacore is supplies systems for protein interaction analysis, used in academia, pharmaceutical, biotechnology and diagnostic companies. Biacore systems generate unique data on the interactions between proteins and other molecules. These data give insights into protein functionality and disease mechanisms, and play a key role in critical decisions needed for efficient development and production of therapeutics.
Protein interaction analysis is required in areas such as antibody characterization, immunogenicity, biotherapeutic development and production. Biacore also provides key manufacturers with a system and ready-to-use kits for determination of food quality and safety.
Further information on Biacore can be found at: www.biacore.com
|
Associate sponsor
|
ID Biomedical is an integrated biotechnology company dedicated to the development of innovative vaccine products. It operates in research, development, manufacturing, sales and marketing from its facilities in Canada and in the United States. ID Biomedical is dedicated to becoming a premier vaccine company with significant marketed products worldwide and an extensive pipeline in both clinical and preclinical development. For further information on ID Biomedical, please visit the Company's website at www.idbiomedical.com
|
BioSante is an emerging pharmaceutical company developing a robust product pipeline of hormone therapy products to treat both men and women.
BioSante also is developing its calcium phosphate nanoparticulate-based platform technology (CAP) for novel vaccines, vaccine adjuvants and drug delivery systems.
|
Synco BioPartners is one of Europes leading Contract Manufacturing Organizations. Focusing exclusively on Biopharmaceuticals and Vaccines, Synco offers a complete range of manufacturing services including fermentation development, downstream process development, assay development and CGMP manufacture for Phase I-III clinical trials and market supply. Synco also offers a filling and lyophilization service, again to CGMP. Synco has an extensive track record of succesful manufacturing project, and is currently engaged in the manufacture of APIs for clinical trials and for European market supply.
|
Current HIV Research aims to cover all the latest and outstanding developments of HIV research. We invite comprehensive review articles and novel and pioneering work in the basic and clinical fields on all areas of HIV research, including virus replication and gene expression, HIV assembly, virus-cell interaction, viral pathogenesis, epidemiology and transmission, anti-retroviral therapy and adherence, drug discovery, the latest developments in HIV/AIDS vaccines and animal models, mechanisms and interactions with AIDS related diseases, and prevention of viral infection. Each issue of the journal contains a series of timely in-depth reviews and original research written by leaders in the field covering a range of current topics on HIV research. Periodically, the journal will invite guest editors to devote an issue on a particular area of HIV research of great interest that increases our understanding of the virus and its complex interaction with the host.
|
|
|
|
